Jill Marie Broadfoot

Insider Reports History

Location
San Diego, CA
Signature
/s/ Nancy E. Denyes, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jill Marie Broadfoot:

Company Role Class Num Shares Value Price $ Report Date Ownership
aTYR PHARMA INC Chief Financial Officer Common Stock 37,296 $36,400 $0.9760 04 Feb 2026 Direct
aTYR PHARMA INC Chief Financial Officer Restricted Stock Unit 0 $14,175 $3.78 03 Feb 2026 Direct
TALPHERA, INC. Director Common Stock 8,547 $7,622 $0.8918 23 Oct 2025 Direct
aTYR PHARMA INC Chief Financial Officer Employee Stock Option (right to buy) 412,500 09 Jan 2026 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27,500 21 Jun 2022 Direct
TALPHERA, INC. Director Stock Option (Right to Buy) 25,600 23 Oct 2025 Direct
Cue Biopharma, Inc. Director Stock Option (right to buy) 24,400 02 Jan 2026 Direct

Insider Reports Filed by Jill Marie Broadfoot

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATYR aTYR PHARMA INC 03 Feb 2026 3 -$1,521 4 Chief Financial Officer 04 Feb 2026, 19:15
ATYR aTYR PHARMA INC 09 Jan 2026 1 $0 4 Chief Financial Officer 09 Jan 2026, 17:42
CUE Cue Biopharma, Inc. 02 Jan 2026 1 $0 4 Director 06 Jan 2026, 16:00
TLPH TALPHERA, INC. 23 Oct 2025 2 $0 4 Director 24 Oct 2025, 16:46
CUE Cue Biopharma, Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:00
CUE Cue Biopharma, Inc. 04 Jun 2025 0 $0 3 Director 06 Jun 2025, 16:00
ATYR aTYR PHARMA INC 03 Feb 2025 3 -$4,740 4 Chief Financial Officer 04 Feb 2025, 18:14
ATYR aTYR PHARMA INC 08 Jan 2025 1 $0 4 Chief Financial Officer 10 Jan 2025, 16:05
TLPH TALPHERA, INC. 24 Jun 2024 2 $0 4 Director 24 Jun 2024, 19:11
ATYR aTYR PHARMA INC 31 May 2024 1 +$8,950 4 Chief Financial Officer 03 Jun 2024, 08:38
ATYR aTYR PHARMA INC 05 Feb 2024 3 -$2,687 4 Chief Financial Officer 06 Feb 2024, 20:18
ATYR aTYR PHARMA INC 05 Jan 2024 1 $0 4 Chief Financial Officer 09 Jan 2024, 19:33
TLPH ACELRX PHARMACEUTICALS INC 10 Oct 2023 2 $0 4 Director 13 Dec 2023, 16:23
ATYR aTYR PHARMA INC 16 Feb 2023 1 $0 4 Chief Financial Officer 21 Feb 2023, 16:04
ATYR aTYR PHARMA INC 03 Feb 2023 3 -$3,696 4 Chief Financial Officer 06 Feb 2023, 18:00
TLPH ACELRX PHARMACEUTICALS INC 15 Jul 2022 2 $0 4 Director 15 Jul 2022, 19:35
/report/000120919122038883-broadfoot-jill-marie-2022-06-21 OTONOMY, INC. 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:31
ATYR aTYR PHARMA INC 24 May 2022 1 $0 4 Chief Financial Officer 26 May 2022, 16:32
ATYR aTYR PHARMA INC 03 Feb 2022 2 $0 4 Chief Financial Officer 07 Feb 2022, 15:56
ATYR aTYR PHARMA INC 13 Jan 2022 1 +$12,980 4 Chief Financial Officer 18 Jan 2022, 07:39
TLPH ACELRX PHARMACEUTICALS INC 20 Nov 2021 2 $0 4 Director 23 Nov 2021, 16:37
TLPH ACELRX PHARMACEUTICALS INC 20 Nov 2021 0 $0 3 Director 23 Nov 2021, 16:34
/report/000120919121052839-broadfoot-jill-marie-2021-08-18 OTONOMY, INC. 18 Aug 2021 1 $0 4 Director 20 Aug 2021, 18:36
/report/000120919121052837-broadfoot-jill-marie-2021-08-18 OTONOMY, INC. 18 Aug 2021 0 $0 3 Director 20 Aug 2021, 18:34
ATYR aTYR PHARMA INC 21 May 2021 1 $0 4 Chief Financial Officer 25 May 2021, 21:04